Success Story: NIW & EB1A Both Approved for a Leading Researcher in Pharmaceutical Sciences Under Premium Processing

Posted by wegreened on June 30, 2026 in NIW, EB1 Green Card

Client’s Testimonial:

"Thank you so much for this wonderful news. I cannot possibly explain in words about how much this approval meant to me. Thank you once again for working on my case meticulously and you have my eternal gratitude!”

On April 29^th, 2025, and April 28^th, 2026, we received another EB-2 NIW (National Interest Waiver) and an EB-1A (Alien of Extraordinary Ability) Approval for a Senior Scientist in the Field of Pharmaceutical Sciences (Approval Notice).

Position at the Time of Case Filing: Senior Scientist

Approval Notice Date: April 29^th, 2025 (NIW) & April 28^th, 2026 (EB1A)

Processing Time: 1 month, 9 days (NIW, Premium Processing Requested) and 3 months, 29 days (EB1A, Premium Processing Requested)

Case Summary:

An EB-2 NIW petition and an EB-1A petition were recently approved for a highly accomplished researcher in pharmaceutical sciences, whose pioneering work in inflammatory pathways, nanoemulsion drug delivery, cancer drug resistance, and Alzheimer's Disease has placed the client among the top tier of researchers in the world.

Excellence in Pharmaceutical Research

With a Ph.D in pharmaceutical sciences, the client has established deep expertise in pharmaceutical research, with a specialized focus on inflammatory diseases, drug delivery systems, cancer drug resistance, and neuroinflammation. The client currently works as a senior scientist at a leading global pharmaceutical company, where they contribute to product life cycle development and validation across multiple high-priority therapeutic programs.

Research Leadership and Global Recognition

The client's scholarly record reflects a rare combination of scientific depth, citation impact, and peer recognition. The client has authored 13 peer-reviewed journal articles (1 first-authored) and accumulated more than 3,000 citations across global scientific communities. The client has completed over 20 peer reviews for high-impact journals.

Expert Endorsements

To strengthen both the NIW and EB-1A filings, our firm included five expert recommendation letters. These experts underscored the client's transformative contributions to drug development and inflammation-targeted therapeutics.

EB1A & NIW Approvals and Outlook

The client's dual approvals, first under the NIW category without RFE in over 1 month, and subsequently under the more demanding EB-1A classification, reflect USCIS's recognition of the client as a leading figure in pharmacology whose sustained contributions benefit the United States. The EB-1A petition received an RFE; our team prepared a comprehensive and well-supported response, and the petition was approved in over 3 months.

Our firm is honored to have represented this distinguished researcher and looks forward to witnessing continued breakthroughs in Inflammatory disease modalities, cancer drug resistance, and Alzheimer's Disease research that will improve patient outcomes and strengthen U.S. leadership in the global pharmaceutical industry for years to come.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%